Dyslipidemia and atherosclerosis: how much more evidence do we need?

被引:10
作者
Illingworth, DR
Durrington, PN
机构
[1] Oregon Hlth & Sci Univ, Dept Med, Div Endocrinol Diabet & Clin Nutr, Portland, OR 97201 USA
[2] Univ Manchester, Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England
关键词
D O I
10.1097/00041433-199910000-00001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:383 / 386
页数:4
相关论文
共 23 条
[1]  
Amer Diabet Assoc, 1998, DIABETES CARE, V21, P179
[2]  
[Anonymous], 1994, CIRCULATION
[3]   Serum cholesterol levels are underevaluated and undertreated [J].
Danias, PG ;
O'Mahony, S ;
Radford, MJ ;
Korman, L ;
Silverman, DI .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (11) :1353-+
[4]   CLINICAL PERSPECTIVES ON PRIMARY AND SECONDARY PREVENTION OF CORONARY ATHEROSCLEROSIS [J].
DEEDWANIA, PC .
MEDICAL CLINICS OF NORTH AMERICA, 1995, 79 (05) :973-+
[5]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[6]   Lipid-lowering drugs: who gets what? [J].
Durrington, PN ;
Illingworth, R .
CURRENT OPINION IN LIPIDOLOGY, 1998, 9 (04) :289-294
[7]  
Færgeman O, 1999, EUR HEART J SUPPL, V1, pJ12
[8]   Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines [J].
Frolkis, JP ;
Zyzanski, SJ ;
Schwartz, JM ;
Suhan, PS .
CIRCULATION, 1998, 98 (09) :851-855
[9]   Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels -: Subgroup analyses in the cholesterol and recurrent events (CARE) trial [J].
Goldberg, RB ;
Mellies, MJ ;
Sacks, FM ;
Moyé, LA ;
Howard, BV ;
Howard, WJ ;
Davis, BR ;
Cole, TG ;
Pfeffer, MA ;
Braunwald, E .
CIRCULATION, 1998, 98 (23) :2513-2519
[10]   Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease [J].
Kugiyama, K ;
Doi, H ;
Takazoe, K ;
Kawano, H ;
Soejima, H ;
Mizuno, Y ;
Tsunoda, R ;
Sakamoto, T ;
Nakano, T ;
Nakajima, K ;
Ogawa, H ;
Sugiyama, S ;
Yoshimura, M ;
Yasue, H .
CIRCULATION, 1999, 99 (22) :2858-2860